THC Therapeutics (THC Therapeutics) Price-to-Operating-Cash-Flow : (As of Jun. 07, 2024)

View and export this data going back to 2007. Start your Free Trial

What is THC Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-06-07), THC Therapeutics's share price is $0.0033. THC Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jul. 2023 was $-0.00. Hence, THC Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for THC Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

THCT's Price-to-Operating-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 16.26
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

THC Therapeutics's Cash Flow from Operations per share for the three months ended in Jul. 2023 was $0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jul. 2023 was $-0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 56.30% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 27.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 25.80% per year.

During the past 13 years, THC Therapeutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 72.00% per year. The lowest was -337.40% per year. And the median was 14.85% per year.

THC Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for THC Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

THC Therapeutics Price-to-Operating-Cash-Flow Chart

THC Therapeutics Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

THC Therapeutics Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of THC Therapeutics's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, THC Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

THC Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, THC Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where THC Therapeutics's Price-to-Operating-Cash-Flow falls into.

THC Therapeutics Price-to-Operating-Cash-Flow Calculation

THC Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.0033	/	-0.004
	=

THC Therapeutics's Share Price of today is $0.0033.
THC Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jul. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

THC Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of THC Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

THC Therapeutics (THC Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » THC Therapeutics Inc (OTCPK:THCT) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

11700 W Charleston Boulevard, No. 73, Las Vegas, NV, USA, 89135

Website

https://thct.io

THC Therapeutics Inc is a United States-based company. It is focused on developing dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis. It will reduce the drying time for cannabis from 10-14 days down to less than 14 hours.

Executives

Hiro Tanaka	director, officer: Vice President	3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Smith Adrian J R	director, officer: Chair of the Board	119 SPRINGLINE DRIVE, VERO BEACH FL 32963
Jamie Mann	director, 10 percent owner, officer: CEO, CFO	3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Eden Ho	director, officer: CEO	701 XUANG MI HU ROAD, XI YUAN, FUTIAN, SHENZHEN F4 XXXXXX